|
1
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: Data
from the Surveillance, Epidemiology, and End Results Program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yan K, Gao J, Yang T, Ma Q, Qiu X, Fan Q
and Ma B: MicroRNA-34a inhibits the proliferation and metastasis of
osteosarcoma cells both in vitro and in vivo. PLoS One.
7:e337782012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Amankwah EK, Conley AP and Reed DR:
Epidemiology and therapies for metastatic sarcoma. Clin Epidemiol.
5:147–162. 2013.PubMed/NCBI
|
|
4
|
Bacci G, Briccoli A, Rocca M, Ferrari S,
Donati D, Longhi A, Bertoni F, Bacchini P, Giacomini S, Forni C, et
al: Neoadjuvant chemotherapy for osteosarcoma of the extremities
with metastases at presentation: Recent experience at the Rizzoli
Institute in 57 patients treated with cisplatin, doxorubicin, and a
high dose of methotrexate and ifosfamide. Ann Oncol. 14:1126–1134.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rainusso N, Wang LL and Yustein JT: The
adolescent and young adult with cancer: State of the art - bone
tumors. Curr Oncol Rep. 15:296–307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Szuhai K, Cleton-Jansen AM, Hogendoorn PC
and Bovée JV: Molecular pathology and its diagnostic use in bone
tumors. Cancer Genet. 205:193–204. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pramoonjago P, Baras AS and Moskaluk CA:
Knockdown of Sox4 expression by RNAi induces apoptosis in ACC3
cells. Oncogene. 25:5626–5639. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Medina PP, Castillo SD, Blanco S,
Sanz-Garcia M, Largo C, Alvarez S, Yokota J, Gonzalez-Neira A,
Benitez J, Clevers HC, et al: The SRY-HMG box gene, SOX4, is a
target of gene amplification at chromosome 6p in lung cancer. Hum
Mol Genet. 18:1343–1352. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liao YL, Sun YM, Chau GY, Chau YP, Lai TC,
Wang JL, Horng JT, Hsiao M and Tsou AP: Identification of SOX4
target genes using phylogenetic footprinting-based prediction from
expression microarrays suggests that overexpression of SOX4
potentiates metastasis in hepatocellular carcinoma. Oncogene.
27:5578–5589. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu P, Ramachandran S, Ali Seyed M,
Scharer CD, Laycock N, Dalton WB, Williams H, Karanam S, Datta MW,
Jaye DL, et al: Sex-determining region Y box 4 is a transforming
oncogene in human prostate cancer cells. Cancer Res. 66:4011–4019.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Scharer CD, McCabe CD, Ali-Seyed M, Berger
MF, Bulyk ML and Moreno CS: Genome-wide promoter analysis of the
SOX4 transcriptional network in prostate cancer cells. Cancer Res.
69:709–717. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dy P, Penzo-Méndez A, Wang H, Pedraza CE,
Macklin WB and Lefebvre V: The three SoxC proteins - Sox4, Sox11
and Sox12 - exhibit overlapping expression patterns and molecular
properties. Nucleic Acids Res. 36:3101–3117. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tavazoie SF, Alarcón C, Oskarsson T, Padua
D, Wang Q, Bos PD, Gerald WL and Massagué J: Endogenous human
microRNAs that suppress breast cancer metastasis. Nature.
451:147–152. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim VN, Han J and Siomi MC: Biogenesis of
small RNAs in animals. Nat Rev Mol Cell Biol. 10:126–139. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Thomson DW, Bracken CP and Goodall GJ:
Experimental strategies for microRNA target identification. Nucleic
Acids Res. 39:6845–6853. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wiemer EA: The role of microRNAs in
cancer: No small matter. Eur J Cancer. 43:1529–1544. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xue Z, Zhao J, Niu L, An G, Guo Y and Ni
L: Up-regulation of miR-300 promotes proliferation and invasion of
osteosarcoma by targeting BRD7. PLoS One. 10:e01276822015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hu J, Lv G, Zhou S, Zhou Y, Nie B, Duan H,
Zhang Y and Yuan X: The downregulation of MiR-182 is associated
with the growth and invasion of osteosarcoma cells through the
regulation of TIAM1 expression. PLoS One. 10:e01211752015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhao F, Lv J, Gan H, Li Y, Wang R, Zhang
H, Wu Q and Chen Y: MiRNA profile of osteosarcoma with CD117 and
stro-1 expression: miR-1247 functions as an onco-miRNA by targeting
MAP3K9. Int J Clin Exp Pathol. 8:1451–1458. 2015.PubMed/NCBI
|
|
21
|
Sun B, Yang M, Li M and Wang F: The
microRNA-217 functions as a tumor suppressor and is frequently
downregulated in human osteosarcoma. Biomed Pharmacother. 71:58–63.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang ZG, Chen WX, Wu YH, Liang HF and
Zhang BX: MiR-132 prohibits proliferation, invasion, migration, and
metastasis in breast cancer by targeting HN1. Biochem Biophys Res
Commun. 454:109–114. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
You J, Li Y, Fang N, Liu B, Zu L, Chang R,
Li X and Zhou Q: MiR-132 suppresses the migration and invasion of
lung cancer cells via targeting the EMT regulator ZEB2. PLoS One.
9:e918272014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zheng YB, Luo HP, Shi Q, Hao ZN, Ding Y,
Wang QS, Li SB, Xiao GC and Tong SL: miR-132 inhibits colorectal
cancer invasion and metastasis via directly targeting ZEB2. World J
Gastroenterol. 20:6515–6522. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang J, Gao T, Tang J, Cai H, Lin L and Fu
S: Loss of microRNA-132 predicts poor prognosis in patients with
primary osteosarcoma. Mol Cell Biochem. 381:9–15. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu Q, Liao F, Wu H, Cai T, Yang L, Wang
ZF and Zou R: Upregulation of miR-132 expression in glioma and its
clinical significance. Tumour Biol. 35:12299–12304. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu X, Yu H, Cai H and Wang Y: The
expression and clinical significance of miR-132 in gastric cancer
patients. Diagn Pathol. 9:572014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang J, Xu G, Shen F and Kang Y: miR-132
targeting cyclin E1 suppresses cell proliferation in osteosarcoma
cells. Tumour Biol. 35:4859–4865. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu WK, Lee CW, Cho CH, Fan D, Wu K, Yu J
and Sung JJ: MicroRNA dysregulation in gastric cancer: A new player
enters the game. Oncogene. 29:5761–5771. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Miao J, Wu S, Peng Z, Tania M and Zhang C:
MicroRNAs in osteosarcoma: Diagnostic and therapeutic aspects.
Tumour Biol. 34:2093–2098. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yin J, Lin J, Luo X, Chen Y, Li Z, Ma G
and Li K: miR-137: A new player in schizophrenia. Int J Mol Sci.
15:3262–3271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Vogelstein B and Kinzler KW: Cancer genes
and the pathways they control. Nat Med. 10:789–799. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nevins JR: The Rb/E2F pathway and cancer.
Hum Mol Genet. 10:699–703. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yao Q, Chen J, Lv Y, Wang T, Zhang J, Fan
J and Wang L: The significance of expression of autophagy-related
gene Beclin, Bcl-2, and Bax in breast cancer tissues. Tumour Biol.
32:1163–1171. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Korbakis D and Scorilas A: Quantitative
expression analysis of the apoptosis-related genes BCL2, BAX and
BCL2L12 in gastric adenocarcinoma cells following treatment with
the anticancer drugs cisplatin, etoposide and taxol. Tumour Biol.
33:865–875. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Huang YW, Liu JC, Deatherage DE, Luo J,
Mutch DG, Goodfellow PJ, Miller DS and Huang TH: Epigenetic
repression of microRNA-129-2 leads to overexpression of SOX4
oncogene in endometrial cancer. Cancer Res. 69:9038–9046. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kang M, Li Y, Liu W, Wang R, Tang A, Hao
H, Liu Z and Ou H: miR-129-2 suppresses proliferation and migration
of esophageal carcinoma cells through downregulation of SOX4
expression. Int J Mol Med. 32:51–58. 2013.PubMed/NCBI
|
|
38
|
Yeh YM, Chuang CM, Chao KC and Wang LH:
MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis
by targeting SOX4 and HIF-1α. Int J Cancer. 133:867–878. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhou X, Li L, Su J and Zhang G: Decreased
miR-204 in H pylori-associated gastric cancer promotes cancer cell
proliferation and invasion by targeting SOX4. PLoS One.
9:e1014572014. View Article : Google Scholar
|
